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Abstract
Background: The number of Acute Dental Infections (ADI) presenting for emergency department (ED) care are
steadily increasing. Outpatient Parenteral Antibiotic Therapy (OPAT) programs are increasingly utilized as an alternative
cost-effective approach to the management of serious infectious diseases but their role in the management of severe
ADI is not established. This study aims to address this knowledge gap through evaluation of ADI referrals to a regional
OPAT program in a large Canadian center.
Methods: All adult ED and OPAT program ADI referrals from four acute care adult hospitals in Calgary, Alberta, were
quantified using ICD diagnosis codes in a regional reporting system. Citywide OPAT program referrals were prospectively
enrolled over a five-month period from February to June 2014. Participants completed a questionnaire and OPAT medical
records were reviewed upon completion of care.
Results: Of 704 adults presenting to acute care facilities with dental infections during the study period 343 (49%) were
referred to OPAT for ADI treatment and 110 were included in the study. Participant mean age was 44 years, 55% were
women, and a majority of participants had dental insurance (65%), had seen a dentist in the past six months (65%) and
reported prior dental infections (77%), 36% reporting the current ADI as a recurrence. Median length of parenteral
antibiotic therapy was 3 days, average total course of antibiotics was 15-days, with a cumulative 1326 antibiotic days
over the study period. There was no difference in total duration of antibiotics between broad and narrow spectrum
regimes. Conservative cost estimate of OPAT care was $120,096, a cost savings of $597,434 (83%) compared with
hospitalization.
Conclusions: ADI represent a common preventable cause of recurrent morbidity. Although OPAT programs may offer
short-term cost savings compared with hospitalization, risks associated with extended antibiotic exposures and delayed
definitive dental management must also be gauged.
Keywords: Periapical abscess, Antibiotics, Healthcare costs, Parenteral infusions, Public health dentistry, Odontogenic
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Background
Despite substantial advances in dental public health over
the past century, recent trends in the United States and
Canada reveal increasing rates of emergency department
(ED) visits and hospitalizations for acute dental infections
(ADI) [1–4]. A parallel trend has been documented in
Europe with Germany, Britain and Finland showing
similarly increased ED visits for ADI [5–7]. While retro-
spective studies in North America and Europe have cha-
racterized this epidemic and estimated associated health
system resource and financial costs, little is known about
the individual and community consequences resulting
from acute medical management, particularly for the vast
majority of patients with ADI who are not hospitalized.
Between 2000 and 2010 non-traumatic dental visits to
EDs in the United States increased from 1.1 to 2.1
million, accounting for an increase in the proportion of
all emergency visits from 1 to 1.5% [8]. Estimates from a
combination of census and provincial reporting data in
Canada reveal that 1.8 million people, representing 5.4%
of the total population, reported one or more dental
visits to EDs over their lifetime [4]. Of non-traumatic
dental visits to EDs in the United States and Canada it is
estimated that dental infections represent 40–60% of
cases [4, 8]. ADIs represent a severe form of dental in-
fection potentially resulting in systemic complications.
Definitive management of ADI requires dental interven-
tion; generally tooth extraction or root canal treatment,
and often hospitalization. Antibiotics may serve a limited
temporizing role pre- and peri-intervention but are not
definitive management alone [9, 10]. Between 2000 and
2008 ADI hospitalization in the United States increased
by 41%, after adjustment for growth, resulting in 8191
admissions in 2008 with attributed healthcare costs
exceeding $105 million [2, 11].
Social determinants of health and related dental health
policy have been shown to play an important role in the
epidemiology of dental infections. Rates of dental visits
to EDs and hospitalization for ADI are highest amongst
individuals who are uninsured and poor [2, 4, 8, 12]. It is
estimated that a quarter of Americans and over a third
of Canadians do not have dental insurance, the propor-
tion uninsured increasing to more than half amongst
those in lower socio-economic groups [13, 14]. Outside
of childhood and a limited number of special popula-
tions programs, routine dental health is not publicly
funded in the United States or Canada [14–16]. In
Canada, hospital and physicians’ services are publicly
funded. However, only about 6% of all dental expendi-
tures are publicly funded [17]. As a result of this lack of
coverage and the division of dental and medical health,
dental infections, although preventable, often progress
ignored by healthcare policy until advanced and
threatening overall medical health.
The vast majority of individuals with non-severe ADI
in Canada never present to the EDs, rather they attend
their dentist or general practitioner for urgent manage-
ment that may entail definitive surgical intervention
and/or temporizing oral antibiotics. Generally it is only
severe cases with refractory pain, significant secondary
facial cellulitis, or limiting trismus that are either
referred to EDs or self attend. Whereas the majority of
severe ADI have historically been managed with
hospitalization, the modern expansion of Out-patient
Parenteral Antibiotic Therapy programs (OPAT) have
allowed for many severe ADI presenting to EDs to now
be managed in the out-patient setting [18].
A detailed overview of OPAT programs has recently
been published elsewhere [19]. Using this model, in
Calgary, Alberta, urgent and emergency medical care fa-
cilities increasingly refer severe ADI that are medically
fit for outpatient management to a regional OPAT pro-
gram administered through each of the four adult acute
care hospitals [20]. This comprehensive program now
receives over 300 ADI referrals per year. As antibiotic
therapy is only a bridge to a permanent solution for the
dental problem, the OPAT program therefore serve as a
point of referral to dental services. Despite the
prevalence of patients with dental disease seeking acute
medical care, to our knowledge there has not been any
published research investigating individuals’ characteris-
tics and the management of ADI through OPAT pro-
grams. To address this information gap, the objectives of
this study were to prospectively assess the socio-medical
profile and clinical management of patients treated for
ADI in Calgary’s OPAT program, and to identify
healthcare cost difference between hospital and OPAT
management.
Methods
This study was prospectively conducted in Calgary,
Alberta, between February 1st and June 30th, 2014.
Designed as a quality improvement study, formal sample
size calculation was not performed. A convenience sample
was used with target sample size informed by the OPAT
referral volumes of the preceding year (average 30 ADI
referrals per month). The present study aimed to enrol 24
participants for each of the five months (N = 120), target-
ing an estimated 80% enrolment of all OPATADI referrals
so as to provide a representative sample. The local health
ethics board approved this study (REB-13-0935).
In our health zone, four EDs and two urgent care facil-
ities provide all acute medical care to the metropolitan area
with a population of approximately 1.2 million and serve as
the ADI referral base (thus representing population based
data). Participant enrollment and data collection took place
in the OPAT program, consisting of four separate sites
operating at each of the acute care facilities. The Calgary
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OPAT program provides community-based parenteral anti-
biotic therapy seven days a week under the guidance of an
infectious diseases physician for indicated infections
following referral. Initial OPAT assessments occurs within
24 h of referral and patients are discharged from the pro-
gram when parenteral antibiotics are no longer needed,
with therapy either transitioned to oral formulation or
discontinued.
Eligible participants for this study were adults, 18 years
of age and older, referred to OPAT for ADI manage-
ment. Patients were excluded if they did not reside in
the Calgary Health Zone to allow population level as-
sessment. For the purpose of this study ADI was defined
as new onset or acute worsening dental focus infection
requiring parenteral antibiotic therapy based upon phys-
ician assessment. Preliminary determination of the need
for parenteral antibiotics in the OPAT setting was made
by the referring ED physician based upon clinical status,
perceived severity of infectious process and/or inability
to take antibiotics orally, and appropriateness of sub-
acute community dental care. Participants completed a
self-administered questionnaire about their medical,
dental and social history at the time of enrollment in the
OPAT program (Additional file 1). A standardized tem-
plate was designed and used by the attending infectious
diseases physician to document the initial medical
assessment and treatment plan (Additional file 2). As
part of the study data analysis, antibiotic regimes were
categorized as broad or narrow spectrum. Broad-
spectrum regimes were defined as consisting of clinda-
mycin alone, ceftriaxone with metronidazole or
amoxicillin-clavulanic acid. Narrow-spectrum regimes
were defined as consisting of cefazolin, penicillin, amoxi-
cillin, cephalexin or cefadroxil with the potential of
concurrent metronidazole.
The total number of patients presenting to acute care
facilities with dental infections (including OPAT referred
and non-referred) during the study period were obtained
from a provincial reporting system according to Inter-
national Statistical Classification of Diseases and Related
Health Problems, 10th Revision, Canada (ICD-10-CA).
Given known limitations in the accuracy of ICD code
data for dental problems in acute care [21], we used the
K04 diagnostic code (diseases of pulp and peri-apical
tissues) so as be specific to potential focal infectious
processes of non-traumatic origin while not missing
cases that may not have been coded using the more spe-
cific peri-apical abscess code (K04.4). Total numbers of
OPAT referred ADI, study participants and those who
declined participation, were obtained from the National
Ambulatory Care Reporting System (NACRS) according
to ICD-10-CA K04 coding [22]. Healthcare cost
estimates were provided through direct communication
with Alberta Health Services Billing Information
Department (December, 2014) and are reported in
Canadian dollars. Cost estimates for hospitalization and
OPAT treatment were calculated based on daily operat-
ing costs alone: $1580 per day citywide average for non-
intensive care medical hospital bed, $288 per day for
OPAT treatment.
An area based social deprivation index was used as a
proxy of participants’ socio-economic status. The index
categorized geographic areas of the city into deprivation
quintiles (5th = greatest deprivation, 1st = least deprivation).
Derivation and validation of this index by Pampalon et al. is
described in detail elsewhere [23, 24]. In brief, 2006
Canadian Census Data was used to determine distribution
of deprivation according to social dimensions over
geographic zones made up of 400 to 700 individuals consti-
tuting the smallest stable census areas. Calgary Zone social
deprivation data was provided by the provincial health
authority and was matched to participants using primary
residence postal code data.
Statistical analysis utilized 2-sided two-sample t-tests
for comparison of continuous binary variables and linear
model based t-tests for comparison of continuous vari-
ables. Social deprivation quintiles were compared with
durations of antibiotics with an F-test using a linear
model and with binary variables using Chi-squared con-
tingency table test. One-way ANOVA using Scheffe’s
method was used for comparisons between antibiotic re-
gimes. Significance was a priori defined as an alpha ≤
0.05 in two-tailed distribution. Data analysis was gener-
ated using SAS software, version 9.4 (Cary, NC, USA).
Results
During the five month-study period 704 individuals pre-
sented to regional EDs and urgent care facilities with
dental infections of which 343 (49%) severe ADI were
referred to the OPAT program. This represented 6% of
all OPAT referrals (343/6206) over this period. One
hundred and ten individuals referred to OPAT with ADI
completed all required documents necessary to be
included in the study (32%). Participant characteristics
are summarized in Table 1.
Clinical data from initial OPAT physician assessment
are presented in Table 2. Of those reporting prior ADI
involving the same tooth, no association with site of
infection (molar vs. non-molar or maxillary vs. mandibu-
lar) was present (p > 0.1). There was also no association
between site of dental infection and the presence of
systemic symptoms or having received antibiotics
preceding presentation to acute care (p > 0.1).
Antibiotic treatment data is summarized in Table 3.
Twenty-two participants (20%) reported completing a
course of antibiotics in the preceding three months and
49 (45%) were actively receiving antibiotics for ADI at
the time of presentation to acute care. Over the study
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period a cumulative 1326 antibiotics days were prescribed
(415 parenteral, 911 oral). Two participants had antimicro-
bial therapy discontinued at initial OPAT assessment and
14 (13%) received a single dose of parenteral antibiotics
before transitioning to oral treatment. Mean duration of
parenteral treatment was significantly longer amongst par-
ticipants with mandibular focus of infection compared to
those with a maxillary focus (4.3 vs. 3.2 day, p = 0.01, 95%
CI [0.3, 1.9]); however, there was no significant difference in
mean total antibiotic (parenteral plus oral) duration when
compared by site of infection (p > 0.1).
Duration of parenteral, oral, and total antibiotic
treatments did not significantly differ by duration of
symptoms prior to OPAT referral (chronic, sub-acute,
acute), presence of systemic symptoms at first OPAT as-
sessment, or report of prior ADI in same tooth (p > 0.1).
Participant who reported antibiotic treatment preceding
presentation to acute care had significantly longer mean
total duration of antibiotics compared with those who
did not (17.4 vs. 13 days, p < 0.001, 95% CI [2.8, 6]) but
there was no significant difference in mean duration of
parenteral therapy, type of antibiotics used, or the
frequency of systemic symptoms between these groups
(p > 0.1).
Using total duration of antibiotics and duration of
parenteral antibiotics as correlates of ADI severity no
significant difference was found when compared by having
a regular dentist (yes vs. no), dentist visit in past six
month, dental insurance status, history of childhood caries
or prior dental infection, net household income below
low-income cut-off, or age (p > 0.1). Average duration of
parenteral antibiotics but not total antibiotics was signifi-
cantly longer amongst female participants compared with
males (4.2 vs. 3.3 days, p = 0.03, 95% CI [0.9, 2.5]).
Comparing broad versus narrow spectrum antibiotic
regimes (defined in Table 3 footnotes), participants who
received broad-spectrum parenteral antibiotics had
shorter mean duration of parenteral therapy (2.5 vs.
4.2 days, p < 0.001, 95% CI [0.8, 2.7]). However when
adjusted for those participants that received only a single
initial dose of ceftriaxone then discharge from OPAT on
oral antibiotics, the mean duration of parenteral therapy
was no longer significantly different (3.2 days broad
spectrum vs. 4.2 days narrow spectrum, p > 0.1). There
was no difference between mean total duration
Table 1 Demographic features of those patient’s referred from
acute care to OPAT for ADI management





18 – 25 10 [9]
26 – 45 52 (47)
46 – 65 40 [37]
> 65 8 [7]
Participant mean age (SD) 43.9 (14.4)
Dental History
‘Brush at least daily’ (n = 108) 98 (91)
Prior cavities (n = 104) 90 (87)
Prior dental infection (n = 109) 84 (77)
Prior ADI in the same tooth 39 [36]
‘Have a regular dentist’ (n = 108) 87 (81)
Visited a dentist in past 6 months 63 (58)
Dental Insurance (n = 107) 70 (65)
Medical History
Diabetes mellitus (n = 108) 7 [6]
Active smoker (n = 100) 53 (53) e
Alcohol consumption > 6 beverage/week (n = 72) 15 [21]
History of cold sores (n = 108) 36 [33]
History of cancer (n = 108) 6 [6]
Currently on immunosuppressiveb (n = 108) 7 [6]
Social Factors
Employed (n = 97) 68 (70)
Social Deprivation Indexc −mean (SD) (n = 100) 3.3 (1.4)
Number reporting income below LICOd (%) (n = 81) 15 [19]
an = 110 unless otherwise specified
bDefined as any dosage of oral or inhaled glucocorticoid, chemotherapy, or
disease-modifying anti-rheumatic drug
cReported as quintiles - 1 = least deprivation, 5 =most deprivation
dLICO = Low Income Cut-Off (‘poverty line’), Statistics Canada defined threshold
below which household is expected to spend 20% more than the average
household on essential needs [40]
eCanadian national smoking prevalence of 16% and Alberta provincial
smoking prevalence of 22% (Statistics Canada, 2012)
Table 2 Participants’ presenting signs and symptoms
OPAT ADI (n = 110)a n (%)
Duration of Symptoms
Acute (1–3 days) 37 [34]
Sub-acute (4–14 days) 55 (50)
Chronic (>14 days) 12 [11]
Onset post dental procedure 6 [5]
Systemic Symptomsb 33 [30]







an = 110 unless otherwise specified
bFever, rigors, nausea, vomiting
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(parenteral plus oral) of broad and narrow spectrum re-
gimes (14.9 days narrow spectrum vs. 15.2 days broad
spectrum, p > 0.1).
The percentage of individuals in each social
deprivation index quintile were: Q5 26%, Q4 18%, Q3
8%, Q2 23%, Q1 25% (5th = most deprived, 1st = least
deprived). Total duration of antibiotics, duration of par-
ental antibiotics, dentist status, dentist visit in past six
month, and dental insurance status were not associated
with social deprivation index quintile (p > 0.1).
Over the 5-month study period, these 110 study par-
ticipants received a total of 417 patient days of OPAT
care, mean length 3.8 days (SD 2.2), averaging an esti-
mated $1094 cost per course of treatment with a total
cumulative cost to the health care system of $120,096.
Estimated cost of hospitalization for the equivalent dur-
ation of parenteral treatment would have been $717,530.
Discussion
In the context of a widespread and sustained increases
in the numbers of individuals with dental infections
presenting to acute medical care, our prospective study
of ADI in the OPAT setting provides novel information
about the clinical management of patients in a large
urban center. Additionally, our study provides contem-
porary insight into the intersection of the dental and
medical healthcare systems in Canada by characterizing
the social-medical profile and quantifying the financial
and healthcare resource costs of those requiring OPAT
care for ADI. The overall severity of dental infections
presenting to acute medical care - in our study 49%
requiring parenteral antibiotics and OPAT referral - and
the related prolonged antibiotic treatment prescribed as
management underscore a significant public health
problem with implications at the individual, population
and health system levels.
Our study’s findings regarding antibiotic treatment on
balance suggest no difference between the antibiotic re-
gimes used. Although, when using duration of parenteral
therapy as a surrogate of early therapy effectiveness,
broader spectrum therapy (ceftriaxone or clindamycin
based regimes) appeared to be more effective, shorter
mean duration of parenteral treatment, this effect is
more likely explained by OPAT practice patterns rather
than differential antibiotic efficacy. The practice of giv-
ing a single dose of an antibiotic with a longer half-life
(i.e. ceftriaxone) to those patients appropriate for oral
step down at initial OPAT assessment appears to be
common in our OPAT program. When cases that
received a single dose of ceftriaxone and were subse-
quently discharged from OPAT after first assessment
were excluded there was no longer a difference in mean
duration of parenteral therapy between those who re-
ceived broad or narrow spectrum regimes. Furthermore,
the mean total duration of antibiotic treatment was not
significantly different between the various treatment
regimes lending support to the use of narrower
spectrum, lower toxicity regimes to avoid antibiotic
associated complications.
Looking beyond individual management, the cumula-
tive 1326 antibiotic days of treatment amongst the 110
participants in this study represents excessive exposure
for a condition that is preventable and for which primary
management entails dental intervention [9, 10, 25].
Table 3 Antibiotic management of ADI
OPAT ADI (n = 110)a
Antibiotic Management
Received Pre-ED/UC PO antibiotics – n (%) 49 (45)
Days of OPAT IV - median (IQR) 3 [2]
Days of Post-OPAT PO – median (IQR) 9 [3]
Total OPAT & Post-OPAT days – median (IQR) 15 [4]
Antibiotic Regime – n (%)
ED/UC prescription (IV) (n = 105)
Cefazolin & metronidazoleb 60 (57)
Clindamycinc 22 [21]
Ceftriaxone & metronidazoleb 13 [12]
Other 10 [10]
OPAT prescription (IV) (n = 108)
Cefazolin & metronidazoleb 84 (78)
Ceftriaxone & metronidazoleb 14 [13]
Clindamycinc 10 [9]
OPAT discharge prescription (PO) (n = 107)
Cephalexin or cefadroxil both with metronidazole 64 (60)
Amoxicillin-clavulanic acid 24 [22]
Clindamycinc 16 [15]
Other 3 [3]
Regime Specific Duration of Antibiotics – days
Parenteral (IV)g p = 0.2
Narrow spectrum IV regime – mean (SD)d 4.2 (2.2)
Broad spectrum IV regime – mean (SD)e 3.2 (1.1)
Total course (IV & PO) (n = 107) p = 0.4
Narrow spectrum regimef – mean (SD) 14.9 (4.3)
Broad spectrum regime# – mean (SD) 15.2 (5.4)
ED emergency department, UC urgent care, IV intravenous, PO oral route, IQR
interquartile range, SD standard deviation
an = 110 unless otherwise specified
bMetronidazole component in either PO or IV formulation
cOf those receiving clindamycin 5 had clinical record of a beta-lactam allergy
dNarrow spectrum IV regime = cefazolin or penicillin both with metronidazole,
PO regime = amoxicillin or cephalexin or cefadroxil with metronidazole
eBroad spectrum IV regime = clindamycin alone or ceftriaxone with
metronidazole, PO regime = amoxicillin-clavulanic acid or clindamycin
fDefined as majority of days of treatment consisting of either broad or narrow
spectrum agents
gExcluding cases where only a single initial dose of ceftriaxone was given and
participants were then discharged on oral antibiotics
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Despite little evidence supporting antibiotic therapy as
management of most types of dental infections – a
recent systematic review on the topic concluded the
quality of available evidence is “very low” [26] - it is
estimated that 8 to10% of all primary care antibiotic pre-
scriptions are for treatment of dental infections [27, 28].
Antibiotic prescription patterns for dental infections in
the acute care setting are less well quantified. Most acute
medical care facilities are not equipped, or do not have
dental professionals available, to provide definitive dental
care, resulting in temporizing analgesics and antibiotics
being the primary management of dental infections in
this setting [29]. Highlighting just how common place
this approach is, a recent study in the United States
found that 56% of emergency room dental visits from a
statewide sample received antibiotic prescriptions [30].
The widespread, potentially avoidable, use of antibi-
otics characterized here and in previous studies on
dental infections in general, raises concern about poten-
tial significant iatrogenic health risks. At the level of the
individual, extended and frequent antibiotic exposures
may increase the risk of antibiotic associated diseases
such as Clostridium difficile colitis [31]. While at the
population level such exposures contribute to the rapidly
expanding public health emergency of bacterial anti-
biotic resistance [32, 33]. Our finding that longer total
courses of antibiotics were prescribed to individuals who
presented to acute care while receiving antibiotics high-
lights a population amongst whom these risks may be
greatest and may benefit most from early triage to dental
intervention.
Whereas severe ADI requiring parenteral antibiotics
were previously managed with hospitalization, OPAT
programs now allow for management in the community
[18]. The impacts of this change on antibiotic prescrip-
tion patterns and the timing of dental interventions have
not yet been studied. We hypothesize that unintended
consequences of OPAT treatment may be deferral of de-
finitive dental intervention that would typically occur if
hospitalized as well as excess durations of parenteral
therapy.
As it has been previously reported that patients prefer
antibiotic treatment and are often unwilling to accept
operative intervention [34], the rapid symptomatic im-
provement of ADI with parenteral therapy may bolster
these preferences and influence convalescent healthcare
choices. Our finding that over a third of study participants
reported recurrent infections might be a reflection of this.
Programmatic features inherent to OPAT management,
such as treatment decisions being confined to clinic work
hours and standardized multi-dose bag drug formulations
used with infusion pumps, may have contributed to longer
courses of parenteral therapy than would be used in the
hospital setting. The relatively long prescriptions of oral
antibiotics (mean of 9 days) seen in our study may in part
reflect uncertainty or delays in the timing of dental care
follow-up and a desire on the part of the prescribing
physician to ensure adequate bridging to definitive
management. Together these issues highlight a need for
improved pathways to dental care along with patient and
physician education around optimal dental infection
management. The infectious diseases expertise of OPAT
teams should facilitate enhanced antimicrobial steward-
ship, however our finding suggests practices in this regard
could be improved. Collaboration with existing hospital
and regional antimicrobial stewardship programs and
implementation of checklists to aid in OPAT service
decisions have been proposed elsewhere [35] and could
further reduce risks associated with ADI antibiotic
management.
Our cost saving findings must be interpreted with cau-
tion as they only capture direct cost estimates of current
medical management practices missing the indirect costs
associated with excess antibiotic use. In-line with previous
OPAT cost-effectiveness research [36], our conservative
estimate of $597,434 (CAN) (83%) cost savings compared
with hospitalization for the full course of parenteral anti-
biotic treatment suggests a role for OPAT programs in
ADI management. However, as OPAT therapy only serves
as a bridge to definitive dental care these cost-savings may
only be short term if not complimented by timely engage-
ment with dental services. Further research evaluating the
comparative cost-effectiveness of OPAT treatment com-
pared with primary prevention and hospital-based dental
interventions is needed to better understand total costs
and inform dental health policy reform.
The socioeconomic profile of participants presenting to
EDs with severe ADI in our study and high rates of re-
ported dental insurance coverage and connection to dental
care without apparent association to social deprivation are
in contrast to findings from previous retrospective studies
on dental infections in acute medical care [11, 12, 37]. In
further contrast, a social gradient has been observed
regionally in Alberta where, between 2007 and 2013,
residents in the lowest income group were twice as likely
compared with the highest income group to seek dental
care in emergency departments (13 visits per 1,000 vs. 6.2
visits per 1,000) [38]. Although our findings may reflect
true demographic differences between the sub-group of
severe ADI evaluated in our study compared to the more
inclusive dental infection populations in previous retro-
spective studies, both selection and information bias may
have also influenced our findings.
Our study has a number of notable limitations. Most
importantly, we captured only a severe subset of ADIs,
those presenting to EDs and felt to require parenteral
antibiotics. How those patients with severe ADIs differ
from the general population experiencing any ADIs
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cannot be established based on our referral base. Fur-
thermore, with only a third of eligible OPAT referrals
participating in the study our sample may not be
representative of the source population. Our use of writ-
ten consent forms and questionnaires may have limited
participation of those illiterate or non-English speaking
while questions about sensitive medical and social infor-
mation may have lead to subject reporting bias. Use of
objective postal code reporting and assigning a
deprivation index accordingly was intended to mitigate
such reporting bias. However, information bias may have
resulted from the social deprivation index itself as it was
based upon census data from 2006 since which time
Calgary has undergone considerable economic growth
resulting in potential shifts in the socioeconomic
composition of communities. Finally, our study did not
capture those patients admitted to hospital with ADI
who may have disproportionately represented lower so-
cioeconomic groups. With regard to our finding of high
rates of reported dental insurance coverage and connec-
tion to dental care, previous research has noted that this
does not necessarily translate into regular access to
dental care as financial barriers, such as excessive
deductibles, and an individual’s resistance to dental
intervention may still remain [15, 30, 39].
The epidemic of dental infections seeking acute medical
care represents a growing public health problem in North
America. Beyond the well-established healthcare costs of
this epidemic, related extensive antibiotic usage poses an
additional public health threat by way of potentially
contributing to bacterial antibiotic resistance. Addressing
these interconnected issues as they relate to ADI demands
improved integration of medical and dental services to
ensure timely definitive management. While OPAT
programs may offer short-term cost-efficiency compared
to hospitalization for the medical management of a se-
lected subset of severe ADI, without improved community
pathways to definitive dental care and adherence to
antimicrobial stewardship best practices these saving may
be outweighed by unintended delays in definitive manage-
ment and risks associated with excessive antibiotic
exposures.
Additional file
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